Evidence map›Paper›PMID 38090786›Full record

Trial reportJournal of medical Internet research2023

A Personalized, Transdiagnostic Smartphone Intervention (Mello) Targeting Repetitive Negative Thinking in Young People With Depression and Anxiety: Pilot Randomized Controlled Trial.

Imogen Bell, Chelsea Arnold, Tamsyn Gilbertson, Simon D'Alfonso, Emily Castagnini, Nicola Chen, Jennifer Nicholas, Shaunagh O'Sullivan, Lee Valentine, Mario Alvarez-Jimenez

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of medical Internet research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Review
  11. Article
  12. Repetitive negative thinking in adolescence: a mixed methods study.Child and adolescent psychiatry and mental health · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Imogen BellOrygen, Melbourne, Australia.ORCID 0000-0001-7567-0517
Chelsea ArnoldOrygen, Melbourne, Australia.ORCID 0000-0003-0839-2304
Tamsyn GilbertsonOrygen, Melbourne, Australia.ORCID 0000-0003-0996-8002
Simon D'AlfonsoOrygen, Melbourne, Australia.ORCID 0000-0001-7407-8730
Emily CastagniniOrygen, Melbourne, Australia.ORCID 0000-0002-7715-2462
Nicola ChenOrygen, Melbourne, Australia.ORCID 0000-0001-6648-6646
Jennifer NicholasOrygen, Melbourne, Australia.ORCID 0000-0003-1889-1107
Shaunagh O'SullivanOrygen, Melbourne, Australia.ORCID 0000-0002-5234-5727
Lee ValentineOrygen, Melbourne, Australia.ORCID 0000-0001-7481-6537
Mario Alvarez-JimenezOrygen, Melbourne, Australia.ORCID 0000-0002-3535-9086

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundRepetitive negative thinking (RNT) is a key transdiagnostic mechanism underpinning depression and anxiety. Using "just-in-time adaptive interventions" via smartphones may disrupt RNT in real time, providing targeted and personalized intervention.

objectiveThis pilot randomized controlled trial evaluates the feasibility, acceptability, and preliminary clinical outcomes and mechanisms of Mello-a fully automated, personalized, transdiagnostic, and mechanistic smartphone intervention targeting RNT in young people with depression and anxiety.

methodsParticipants with heightened depression, anxiety, and RNT were recruited via social media and randomized to receive Mello or a nonactive control over a 6-week intervention period. Assessments were completed via Zoom sessions at baseline and at 3 and 6 weeks after baseline.

resultsThe findings supported feasibility and acceptability, with high rates of recruitment (N=55), uptake (55/64, 86% of eligible participants), and retention (52/55, 95% at 6 weeks). Engagement was high, with 90% (26/29) and 59% (17/29) of the participants in the Mello condition still using the app during the third and sixth weeks, respectively. Greater reductions in depression (Cohen d=0.50), anxiety (Cohen d=0.61), and RNT (Cohen d=0.87) were observed for Mello users versus controls. Mediation analyses suggested that changes in depression and anxiety were accounted for by changes in RNT.

conclusionsThe results indicate that mechanistic, targeted, and real-time technology-based solutions may provide scalable and effective interventions that advance the treatment of youth mental ill health.

trial registrationAustralian New Zealand Clinical Trials Registry ACTRN12621001701819; http://tinyurl.com/4d3jfj9f.

Indexed as

PessimismSmartphoneAdolescentAnxietyAustraliaDepressionHumansPilot Projectsadolescentanxietydepressionjust-in-time adaptive interventionsmobile appmobile phonerepetitive negative thinkingruminationyouth mental health

Identifiers

PMID38090786
PMCPMC10753417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.